scispace - formally typeset
J

Jatta Berberat

Researcher at University of Geneva

Publications -  44
Citations -  384

Jatta Berberat is an academic researcher from University of Geneva. The author has contributed to research in topics: Medicine & Stroke. The author has an hindex of 10, co-authored 33 publications receiving 262 citations.

Papers
More filters
Journal ArticleDOI

Differentiation between calcification and hemorrhage in brain tumors using susceptibility-weighted imaging: a pilot study.

TL;DR: In this article, the authors developed a robust method to differentiate calcification from hemorrhage in gliomas using phase shift values for calcification and hemorrhage compared with normal brain, whereas CT showed substantial overlap of Hounsfield units.
Journal ArticleDOI

Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience.

TL;DR: The ElutaxDEB may be a promising alternative treatment for patients with symptomatic high-grade intracranial stenosis showing a significantly lower rate of ischemic re-events or restenosis in comparison with the WingspanStent-treated patients with a similar safety profile.
Journal ArticleDOI

Diffusion tensor imaging for target volume definition in glioblastoma multiforme.

TL;DR: Extending the CTV along the abnormal tensor tracts in order to preserve coverage of the likely routes of dissemination, whilst sparing uninvolved brain, is a rational approach to individualising radiotherapy planning for glioblastoma patients.
Journal ArticleDOI

The Optic Canal: A Bottleneck for Cerebrospinal Fluid Dynamics in Normal-Tension Glaucoma?

TL;DR: Narrower OCAs might contribute to a discontinuity of the cerebrospinal fluid flow between the intracranial and orbital subarachnoid space in NTG patients, which might have an influence onto the pathophysiology of NTG.
Journal ArticleDOI

Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study.

TL;DR: In this pilot study, SeQuent Please NEO DCB was feasible and safe in the treatment of symptomatic intracranial severe stenosis and might represent a promising alternative to medical treatment in selected cases.